Literature DB >> 27353822

Ovarian cancer screening: UKCTOCS trial - Authors' reply.

Ian J Jacobs1, Mahesh Parmar2, Steven J Skates3, Usha Menon4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27353822     DOI: 10.1016/S0140-6736(16)30849-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Haley A Moss; Andrew Berchuck; Megan L Neely; Evan R Myers; Laura J Havrilesky
Journal:  JAMA Oncol       Date:  2018-02-01       Impact factor: 31.777

2.  Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation.

Authors:  Ben Kearns; Jim Chilcott; Sophie Whyte; Louise Preston; Susi Sadler
Journal:  BMC Med       Date:  2016-12-06       Impact factor: 8.775

3.  Complications from Surgeries Related to Ovarian Cancer Screening.

Authors:  Lauren A Baldwin; Edward J Pavlik; Emma Ueland; Hannah E Brown; Kelsey M Ladd; Bin Huang; Christopher P DeSimone; John R van Nagell; Frederick R Ueland; Rachel W Miller
Journal:  Diagnostics (Basel)       Date:  2017-03-08

4.  The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease.

Authors:  Paul M Trembling; Sophia Apostolidou; Aleksandra Gentry-Maharaj; Julie Parkes; Andy Ryan; Sudeep Tanwar; Matthew Burnell; Scott Harris; Usha Menon; William M Rosenberg
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.